FDA Investigator Guillermo
Guillermo has inspections in 1 countries as of 28 Aug 2023. Guillermo has collaborated with a combined 1715 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
54
Last Inspection Date:
28 Aug 2023
Investigator Role:
FDA Investigator (Contractor)
Redica ID:
Country:
United States of America
Co-Investigator(s):
Ademola O Daramola,
Alan L Truong,
Alexandra B Pitkin,
Ana Djurdjevic,
Angela Shepas,
Arnold C Shih,
Babajide Michael Osunsanmi,
Belinda E Clifton,
Bonnie I Needleman,
Bowman,
Bradley E Tufto,
Brenda K Alford,
Brian E Thompson,
Burnsb,
Carla J Lundi,
Carr Sharpe,
Celena Ngo,
Comyar Shoghi,
Connie Ng,
Cristina E Mosquera,
David H Hsu,
Davis,
Deborah W Hsu,
Debra J Fracassa,
Dejon N Harris,
Dennis N Hoang,
Desiree C Iya,
Doretha M Wilson,
Elizabeth M Dahl,
Emily M Morrison,
Erik D Sandvig,
Fe Q Reyes,
Gabriel Craig,
Garciam,
Gavin T Cua,
Geoffrey M Leist,
Gordon Chu,
Greg K Keshishyan,
Henry E Carrillo,
Hoover,
Jake T Lane,
James A Barreto,
Jazmine M Welcher,
Jeff M Uriarte,
Jinnie Kokiatkulkij,
Jocelyn E Massey,
Joel D Hustedt,
John A Liu,
John R Myung,
Joseph C Francisco,
Judy C Nepsa,
Julia Ventura,
Kai Wang,
Kaitlyn R Kornberg,
Kawshalya Pathiraja,
Kelley,
Kevin Lee,
Kham Phommachanh,
Kim A Bellama,
Krista K Petersen,
Lakecha N Lewis,
Leticia I Romero,
Lilian Araiza Saita,
Lilly O Barton,
Lin Liu,
Maxyne T Lam,
Michael S Call,
Myers,
Natalie J Ayoub,
Natalie J Reese,
Naveen B Walker,
Ngoc T Le,
Nianna C Burns,
Nicholas J Lahey,
Nicholas L Hunt,
Pamela Y Lee,
Phal K Chhun,
Phillip L Toy,
Randy L Elsberry,
Richard W Tubb,
Richmond K Yip,
Robert C Hoover,
Rochelle A Rolnik,
Rocio Guzman Velazquez,
Romero,
Sara Jdent Acosta,
Sarah A Hassas,
Sarah R Barker,
Sean P Desbrow,
Sharon K Ferguson,
Sparky L Bartee,
State Agency,
Sundy V Sedwick,
Sundy Ven,
Tamala P Bogan,
Tamala P Magee,
Tamara L Alexander,
Tammy Vasquez Hancock,
Tawny L Colling,
Terry L Boles,
Thao T Kwan,
Truong Xuan Nguyen (Andy),
Trushani T Desai,
Uttaniti Limchumroon (Tom),
Victor H Loo,
Yvette Mlacour Davis,
Yvonne T Lacour
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more